Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer

Jiayi Huang, Larry L. Kestin, Hong Ye, Michelle Wallace, Alvaro A. Martinez, Frank A. Vicini

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Abstract

Purpose: To clarify the risk of developing second primary cancers (SPCs) after radiotherapy (RT) versus prostatectomy for localized prostate cancer (PCa) in the modern era. Methods: The RT cohort consisted of 2120 patients matched on a 1:1 basis with surgical patients according to age and follow-up time. RT techniques consisted of conventional or two-dimensional RT (2DRT, 36%), three-dimensional conformal RT and/or intensity modulated RT (3DCRT/IMRT, 29%), brachytherapy (BT, 16%), and a combination of 2DRT and BT (BT boost, 19%). Results: The overall SPC risk was not significantly different between the matched-pair (HR 1.14, 95% CI 0.94-1.39), but the risk became significant >5 years or >10 years after RT (HR 1.86, 95% CI 1.36-2.55; HR 4.94, 95% CI 2.18-11.2, respectively). The most significant sites of increased risk were bladder, lymphoproliferative, and sarcoma. Of the different RT techniques, only 2DRT was associated with a significantly higher risk (HR 1.76, 95% CI 1.32-2.35), but not BT boost (HR 0.83, 95% CI 0.50-1.38), 3DCRT/IMRT (HR 0.81, 95% CI 0.55-1.21), or BT (HR 0.53, 95% CI 0.28-1.01). Conclusions: Radiation-related SPC risk varies depending on the RT technique and may be reduced by using BT, BT boost, or 3DCRT/IMRT.

Original languageEnglish
Pages (from-to)81-86
Number of pages6
JournalRadiotherapy and Oncology
Volume98
Issue number1
DOIs
StatePublished - Jan 2011

Keywords

  • Matched-pair analysis
  • Prostate cancer
  • Radiation therapy
  • Second malignancies
  • Surgery

Fingerprint

Dive into the research topics of 'Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer'. Together they form a unique fingerprint.

Cite this